NO143903C - Analogifremgangsmaate for fremstilling av terapeutisk aktive 5-fluorpyrimidin-4-on-derivater - Google Patents

Analogifremgangsmaate for fremstilling av terapeutisk aktive 5-fluorpyrimidin-4-on-derivater

Info

Publication number
NO143903C
NO143903C NO762664A NO762664A NO143903C NO 143903 C NO143903 C NO 143903C NO 762664 A NO762664 A NO 762664A NO 762664 A NO762664 A NO 762664A NO 143903 C NO143903 C NO 143903C
Authority
NO
Norway
Prior art keywords
fluorpyrimidin
derivatives
preparation
therapeutic active
analogy procedure
Prior art date
Application number
NO762664A
Other languages
English (en)
Norwegian (no)
Other versions
NO762664L (da
NO143903B (no
Inventor
Mitugi Yasumoto
Junichi Yamashita
Ichiro Yamawaki
Kenji Kitazato
Norio Unemi
Sadao Hashimoto
Setsuro Fujii
Original Assignee
Taiho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP50150936A external-priority patent/JPS6011032B2/ja
Priority claimed from JP15093775A external-priority patent/JPS6011033B2/ja
Application filed by Taiho Pharmaceutical Co Ltd filed Critical Taiho Pharmaceutical Co Ltd
Publication of NO762664L publication Critical patent/NO762664L/no
Publication of NO143903B publication Critical patent/NO143903B/no
Publication of NO143903C publication Critical patent/NO143903C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO762664A 1975-12-16 1976-07-30 Analogifremgangsmaate for fremstilling av terapeutisk aktive 5-fluorpyrimidin-4-on-derivater NO143903C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP50150936A JPS6011032B2 (ja) 1975-12-16 1975-12-16 ２―置換―５―フルオルピリミジン―４―オン誘導体の製造法
JP15093775A JPS6011033B2 (ja) 1975-12-16 1975-12-16 ５‐フルオルピリミジン―４―オン誘導体の製造法

Publications (3)

Publication Number Publication Date
NO762664L NO762664L (da) 1977-06-17
NO143903B NO143903B (no) 1981-01-26
NO143903C true NO143903C (no) 1981-05-06

Family

ID=26480366

Family Applications (1)

Application Number Title Priority Date Filing Date
NO762664A NO143903C (no) 1975-12-16 1976-07-30 Analogifremgangsmaate for fremstilling av terapeutisk aktive 5-fluorpyrimidin-4-on-derivater

Country Status (12)

Country Link
US (1) US4080455A (da)
AU (1) AU505440B2 (da)
CA (1) CA1063606A (da)
CH (2) CH621544A5 (da)
DE (1) DE2633359C3 (da)
DK (1) DK137957B (da)
FI (1) FI61885C (da)
FR (1) FR2335228A1 (da)
GB (1) GB1501537A (da)
NL (1) NL162643C (da)
NO (1) NO143903C (da)
SE (1) SE439159B (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR68935B (da) * 1976-03-31 1982-03-29 Takeda Chemical Industries Ltd
JPS5446791A (en) * 1977-09-22 1979-04-12 Takeda Chem Ind Ltd Fluorouracil derivative
US4343940A (en) * 1979-02-13 1982-08-10 Mead Johnson & Company Anti-tumor quinazoline compounds
US20080161324A1 (en) * 2006-09-14 2008-07-03 Johansen Lisa M Compositions and methods for treatment of viral diseases
CN102532039B (zh) * 2010-09-29 2014-03-26 浙江工业大学 一种5-氟嘧啶-4(3h)-酮类化合物在制备抗肿瘤药物中的应用
CN101955465B (zh) * 2010-09-29 2012-07-04 浙江工业大学 一种5-氟嘧啶-4(3h)-酮类化合物及其制备方法和应用
CN102659689B (zh) * 2012-05-16 2014-12-17 浙江工业大学 4-取代-2-丁氧基-5-氟嘧啶类化合物及其制备方法和应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2802005A (en) * 1957-08-06 S-eluorourace
US3784693A (en) * 1972-10-18 1974-01-08 Sandoz Ag 3-substituted phenyl-quinazoline-4(3h)-ones as sedative hypnotics
CH579057A5 (da) * 1973-09-07 1976-08-31 Hoffmann La Roche

Also Published As

Publication number Publication date
FI61885B (fi) 1982-06-30
NL162643C (nl) 1980-06-16
GB1501537A (en) 1978-02-15
FI762166A (da) 1977-06-17
CH621544A5 (da) 1981-02-13
US4080455A (en) 1978-03-21
DE2633359C3 (de) 1981-12-17
DK137957B (da) 1978-06-12
FR2335228B1 (da) 1978-11-17
SE439159B (sv) 1985-06-03
NO762664L (da) 1977-06-17
DE2633359A1 (de) 1977-06-30
NL7608537A (nl) 1977-06-20
SE7608306L (sv) 1977-06-17
CA1063606A (en) 1979-10-02
AU505440B2 (en) 1979-11-22
NO143903B (no) 1981-01-26
DK137957C (da) 1978-11-06
FR2335228A1 (fr) 1977-07-15
FI61885C (fi) 1982-10-11
AU1547576A (en) 1978-01-05
DK346176A (da) 1977-06-17
DE2633359B2 (de) 1980-12-04
NL162643B (nl) 1980-01-15
CH625230A5 (da) 1981-09-15

Similar Documents

Publication Publication Date Title
NO147243C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive ftalanderivater
NO147450C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive kinazolonderivater
NO151321C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive karbostyrilderivater
NO151463C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive kinazolinderivater
NO151411C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1-aryloksy-2-hydroksy-3-alkylenaminopropan-derivater
NO148453C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive spirohydantoinderivater
NO800881L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive kinolonderivater
NO145792C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive pyrimidon-derivater
NO151040C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 5-halogenpyrimid-2-oner
NO146396C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrimidinderivater.
NO144848C (no) Analogifremgangsmaate til fremstilling av terapeutisk virksomme 4-hydroksyfenylalkanolamin-derivater
NO148777C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive antrakinon-derivater
NO146865C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 16-dehydro-androstanderivater
NO145791C (no) Analogifremgangsmaate ved fremstilling av nye terapeutisk aktive imidazolderivater
NO150044C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tetrazol-derivater
NO146359C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive cyproheptadinderivater
NO142838C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive isokinolinderivater
NO148291C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive basisk substituerte teofyllinderivater
NO148488C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive acyl-benzimidazol-2-derivater
NO145238C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive dihydrokarbostyril-derivater
NO143903C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 5-fluorpyrimidin-4-on-derivater
NO147485C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 8-aminomethylisoflavonderivater
NO146672C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive cinnolinderivater
NO794318L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive spiro-kinolyl-hydantoin-derivater
NO144741C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tiopyrano-pyrazoler